North America Newborn Screening Market- Industry Trends and Forecast to 2025

  • In Vitro Diagnostics
  • Publish Reports
  • North America
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220
North America Newborn Screening Market By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases Test), Product Type (Instruments, Reagents & Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays And Enzymatic Assays, Electrophoresis, DNA-Based Assays), Diseases Type (Phenylketonuria, Cystic Fibrosis, Sickle Cell Disease, Newborn Hearing Loss, Critical Congenital Heart Diseases, Maple Syrup Urine Disease), End User (Hospital, Pediatric Clinics, Clinics), By Country (U.S., Canada, Mexico)- Industry Trends and Forecast to 2025 North America Newborn Screening Market is expected to reach USD 1,018.49 million by 2025, growing at a CAGR of 10.6% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. The major factors contributing to the growth of the market includes factors such as rising prevalence of new born screening and technological advancements in screening.

Market Segmentation: North America Newborn Screening Market

  • The North America newborn screening market is segmented on the basis of test types into dried blood spot (DBS) test, critical congenital heart diseases (CCHD) test and hearing screen test. In 2018, dried blood spot segment is anticipated to lead the market with a share of around 43.0%.
  • The North America newborn screening market is segmented on the basis of product type into instruments and reagents & assay kits. In 2018, the instruments segment is estimated to dominate market and is projected to reach rising at the maximum CAGR of 10.9%. The instruments segment is further sub-segmented into newborn disorder screening, newborn hearing screening, and pulse oximeter.
  • The North America newborn screening market is segmented on the basis of technologies into tandem mass spectrometry, hearing screen, pulse oximetry screening, immunoassays and enzymatic assays, electrophoresis and DNA-based assays. In 2018, tandem mass spectrometry segment is likely to dominate market and is projected to reach 295.44 million by 2025. Also, it is growing at the highest CAGR in the forecast period.
  • The North America newborn screening market is segmented on the basis of disease type into phenylketonuria, cystic fibrosis, sickle cell disease, newborn hearing loss, critical congenital heart diseases, maple syrup urine disease and others. In 2018, critical congenital heart diseases segment will dominate the market.
  • The North America newborn screening market is divided on the basis of end user into hospitals, pediatric clinics, and clinics. In 2018, hospitals segment is expected to dominate market.

Key Drivers: North America Newborn Screening Market

Some of the major factors driving the market for North America newborn screening market are raising prevalence of new born screening and technological advancements in screening.

Key Points: North America Newborn Screening Market

PerkinElmer Inc. is going to dominate the North America new born screening market followed by Natus Medical Incorporated and Trivitron Healthcare. PerkinElmer Inc., Trivitron Healthcare, Interacoustics A/S, Bio-Rad Laboratories, Inc., Natus Medical Incorporated, Masimo, Medtronic, Intelligent Hearing Systems, Interacoustics A/S, Otodynamics Ltd, Vivosonic Inc., ZenTech S.A., AB Sciex, Welch Allyn, Baebies, Inc.
  • The dried blood spot segment is dominating the North America new born screening market.
  • The instruments segment is projected to grow at the highest CAGR in the forecast period 2018 to 2025.

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $3200.00
  • $2500.00
BUY NOW ADD TO CART